Effect of different storage temperatures, sample collection procedures and immunoassay methods on osteocalcin measurement

European Journal of Clinical Chemistry and Clinical Biochemistry

Volumn 34, Issue 10, 1996, Pages 841-844

  Noonan, Kate ^a   Kalu, Mary E ^a   Holownia, Peter ^a   Burrin, Jacky M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCALCIN;

ADULT; ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; CATTLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; MALE; NORMAL HUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; SAMPLING; STATISTICAL ANALYSIS;

ADULT; AGED; ANIMALS; BLOOD SPECIMEN COLLECTION; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; RADIOIMMUNOASSAY; TEMPERATURE;

BOS TAURUS; BOVINAE;

EID: 0029851241     PISSN: 09394974     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Price PA, Parthemore JG, Deftos LF. New biochemical marker for bone metabolism: measurement by radioimmunoassay of bone gla-protein in the plasma of normal subjects and patients. J Clin Invest 1980; 66:878-3.
2. Brown JP, Delmas PD, Malaval L, Edouard C, Chapuy MC, Meunier PJ. Serum bone Gla protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1984; 1:1091-3.
3. Deftos LJ. Bone protein and peptide assays in the diagnosis and management of skeletal disease. Clin Chem 1991; 37:1143-8.
4. Rosen HN, Moses AC, Gundberg C, Kung VT, Seyedin SM, Chen T, et al. Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans. J Clin Endocrinol Metab 1993; 77:664-9.
5. Garnero P, Shik WJ, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994; 79:1693-700.
6. Power MJ, Fottrell PF. Osteocalcin: diagnostic methods and clinical applications. Crit Rev Clin Lab Sei 1991; 28:287-335.
7. Tarallo P, Balland M, Henny J. Effect of long term storage on human plasma osteocalcin level. Clin Chim Acta 1992; 208:237-9.
8. Power MJ, O'Dwyer B, Breen E, Fottrell PF. Osteocalcin concentrations in plasma prepared with different anticoagulants. Clin Chem 1991; 37:281-4.
9. Banfi G, Daverio R. In vitro stability of osteocalcin. Clin Chem 1994; 40:833-4.
10. Durham BH, Robinson J, Fraser WD. Differences in the stability of intact osteocalcin in serum, lithium heparin plasma and EDTA plasma. Ann Clin Biochem 1995; 32:422-3.
11. Blumsohn A, Hannon RA, Eastell R. Apparent instability of osteocalcin in serum as measured with different commercially available assays. Clin Chem 1995; 41:318-9.
12. Deftos LJ, Wolfert RL, Hill CS, Burton DW. Two-site assays of bone gla protein (osteocalcin) demonstrate immunochemical heterogeneity of the intact molecule. Clin Chem 1992; 38:2318-21.
13. Garnero P, Grimaux M, Seguin P, Delmas PD. Characterisation of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Min Res 1994; 9:255-64.
14. Masters PW, Jones RG, Purves DA, Cooper EH, Cooney JM. Commercial assays for serum osteocalcin give clinically discordant results. Clin Chem 1994; 40:358-63.
15. Delmas PD, Christiansen C, Mann KG, Price PA. Bone Gla protein (osteocalcin) assay standardisation report. J Bone Miner Res 1990; 5:5-11.
16. Taylor AK, Linkart S, Mohan S, Chrinstenson RA, Singer FR, Baylink D. Multiple osteocalcin fragments in human urine and serum as detected by a midmolecule osteocalcin radioimmunoassay. J Clin Endocrinol Metab 1990; 70:467-72.
17. Van Oss CJ. Antigen-antibody reactions. In: van Regenmortel MHU, editor. Structure of antigens. Boca Raton: CRC Press 1992:99-125.